SIGNATUREFD, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,482
-10.9%
580.0%0.00%
Q2 2023$1,663
+19.6%
580.0%0.00%
Q1 2023$1,390
-5.8%
58
-33.3%
0.00%
Q4 2022$1,476
-26.2%
87
-17.9%
0.00%
Q3 2022$2,000106
+657.1%
0.00%
Q2 2022$0
-100.0%
14
-92.9%
0.00%
Q1 2022$5,000
+66.7%
198
+191.2%
0.00%
Q4 2021$3,000
+50.0%
68
+54.5%
0.00%
Q3 2021$2,000
+100.0%
44
+37.5%
0.00%
Q2 2021$1,000320.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders